Sageworth Trust’s Labcorp LH Stock Holding History

Sageworth Trust’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-1	Closed	–	–	281
2020 Q2	$0	Buy	+1	New	+$138	﹤0.01%	290
2017 Q3	–	Sell	-460	Closed	-$61K	–	94
2017 Q2	$61K	Buy	+460	New	+$56.3K	0.01%	58

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MCM

Melvin Capital Management New York $9.86B AUM 16.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Sageworth Trust's LH Position: Q3 2020 in Review

Sageworth Trust sold out of Labcorp (LH) in Q3 2020, closing a stake of 1 share.

Sageworth Trust first reported a position in LH in Q2 2017 and held it in 2 quarters. The position peaked at $61K in Q2 2017. 809 funds tracked by Wall St. Rank hold LH as of Q3 2020.

Sageworth Trust reported no remaining Labcorp position as of Q3 2020 after selling out during the quarter.
Sageworth Trust sold 1 Labcorp share in Q3 2020.
Sageworth Trust first reported a position in Labcorp in Q2 2017 and held it in 2 quarters.
Sageworth Trust's Labcorp position peaked at $61K in Q2 2017.
809 funds tracked by Wall St. Rank held Labcorp as of Q3 2020.

Based on Sageworth Trust's 13F filing for Q3 2020, filed 4 Nov 2020.